https://doi.org/10.1016/j.celrep.2015.07.014
D
Damon J. Tumes
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
3.6K
Citations
29
h-index
43
i10-index
Damon J. Tumes is an academic researcher from South Australia Pathology. The author has contributed to research in topics: Immune Cell Function and Interaction & T-cell and B-cell Immunology & Asthma and respiratory diseases. The author has an h-index of 29, co-authored 66 publications.
ORCID: 0000-0001-5709-857XPapers by this author
worksObesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1
2015 · Cell Reports · 242 citations
AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
2021 · Cell Reports Medicine · 35 citations
https://doi.org/10.1016/j.xcrm.2021.100464
Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models
2022 · Cell Death and Disease · 31 citations
https://doi.org/10.1038/s41419-022-04589-z
Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans
2024 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-024-54345-4
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-70321-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat